Growth Metrics

Burning Rock Biotech (BNR) Receivables - Net (2019 - 2025)

Burning Rock Biotech has reported Receivables - Net over the past 7 years, most recently at $23.9 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 13.0% year-over-year to $23.9 million; the TTM value through Dec 2025 reached $23.9 million, up 13.0%, while the annual FY2025 figure was $24.3 million, 16.46% up from the prior year.
  • Receivables - Net for Q4 2025 was $23.9 million at Burning Rock Biotech, down from $25.8 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $26.5 million in Q2 2025 and troughed at $11.6 million in Q1 2021.
  • A 5-year average of $18.6 million and a median of $18.5 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: dropped 15.0% in 2021 and later surged 40.6% in 2022.
  • Year by year, Receivables - Net stood at $14.4 million in 2021, then increased by 7.21% to $15.5 million in 2022, then rose by 13.97% to $17.6 million in 2023, then rose by 20.11% to $21.2 million in 2024, then increased by 13.0% to $23.9 million in 2025.
  • Business Quant data shows Receivables - Net for BNR at $23.9 million in Q4 2025, $25.8 million in Q3 2025, and $26.5 million in Q2 2025.